難易度の高い静脈注入患者の中枢静脈対短い中線カテーテル:ランダム化臨床パイロット試験
Carl Mellander1,2,3, Stefanie Seifert4,2, Fredrik Hammarskjöld4,2
1Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden carl.mellander@liu.se.
BMJ open
|February 13, 2026
まとめ
この試験試験では,静脈内へのアクセス困難 (DIVA) の患者の中枢静脈カテーテル (CVC) と短い中間線カテーテル (SML) の比較は,より大きな試験で実現可能であることが判明しました. しかし,皮膚パンクションの試みやSMLの機能不全に関する課題には注意が必要です.
科学分野:
- 血管へのアクセス装置
- 臨床試験の方法論 臨床試験の方法論
- 患者の安全性についてです.
背景:
- 難易度の高い静脈内投与 (DIVA) の患者は,複数の失敗した試行からリスクに直面します.
- 限られた証拠は,DIVA患者の短いミドルラインカテーテル (SMLs) と中央静脈カテーテル (CVCs) を比較しています.
研究 の 目的:
- DIVA患者のSMLとCVCを比較する大規模なランダム化対照試験の可行性を評価する.
- 適格性,採用,留守,遵守,データの完全性,皮膚穿刺の試みなど,事前に定義された実現可能性の結果を評価します.
主な方法:
- プラグマティック,オープン・ラベル,シングル・センター・パイロット・ランダム化・コントロール・トライアル.
- 4〜29日のIV治療を必要とする成人DIVA患者は,SMLまたはCVCにランダムに割り当てられました.
- 実現可能性のアウトカムと二次的なアウトカム (停留時間,合併症) を評価した.
主要な成果:
- 30人の患者がランダムに選択された (15 SML, 15 CVC); 55%の適格率.
- 保持 (93%),遵守 (97%) と欠落したデータ (0%) が基準を満たした.
- 皮膚パンクションの試行 (52% ≥2回の試行) とSML機能障害 (58%対CVCの7%) が重要な結果でした.
結論:
- DIVA患者のSMLとCVCを比較するより大きなランダム化対照試験は実現可能である.
- 皮膚パンクチャーとSMLのパフォーマンスの実用的な課題が特定されました.
- 発見は,最適な患者ケアのための最終的な試験の設計にインフォームします.
キーワード:
大人の麻酔用大人の麻酔用実現可能性研究 (Feasibility Studies) とは,実現可能性に関する研究です.病院 病院についてインテンシブ・クリティカルケア人を中心としたケアランダム化統制試験についてさらに関連する動画
関連する概念動画
Clinical Trials
10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.9K
Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Statistical Software for Data Analysis and Clinical Trials
1.6K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
354
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
354
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
1.5K
Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
One of the advantages of...
1.5K
Pilot and Numeric Relaying
496
Pilot relaying is a type of differential protection used in power systems. It compares electrical quantities at the terminals of equipment via a communication channel instead of direct relay interconnection. This method is essential for transmission lines where the terminals are far apart, typically up to 80 km for lines with 69 to 115 kV ratings. Four types of communication channels are used for pilot relaying:
496


